APA (7th ed.) Citation

Brighi, N., Conteduca, V., Gurioli, G., Scarpi, E., Lolli, C., Schepisi, G., . . . De Giorgi, U. (2021). 601P The prognostic role of longitudinal assessment of plasma androgen receptor (AR) copy number (CN) in metastatic castration-resistant prostate cancer (mCRPC): Analysis from a prospective biomarkers trial. Annals of Oncology, 32, S645. https://doi.org/10.1016/j.annonc.2021.08.1114

Chicago Style (17th ed.) Citation

Brighi, N., et al. "601P The Prognostic Role of Longitudinal Assessment of Plasma Androgen Receptor (AR) Copy Number (CN) in Metastatic Castration-resistant Prostate Cancer (mCRPC): Analysis from a Prospective Biomarkers Trial." Annals of Oncology 32 (2021): S645. https://doi.org/10.1016/j.annonc.2021.08.1114.

MLA (9th ed.) Citation

Brighi, N., et al. "601P The Prognostic Role of Longitudinal Assessment of Plasma Androgen Receptor (AR) Copy Number (CN) in Metastatic Castration-resistant Prostate Cancer (mCRPC): Analysis from a Prospective Biomarkers Trial." Annals of Oncology, vol. 32, 2021, p. S645, https://doi.org/10.1016/j.annonc.2021.08.1114.